Chemycal has been acquired by 3E

Learn More

ECHA Board of Appeal: SCAS Europe S.A./N.V., Belgium | REACH Regulation >> Resorcinol substance evaluation

Your substances


This news contains references also to other Substances

Subject matter: A decision taken by the European Chemicals Agency pursuant to Article 46(1) of the REACH Regulation

Contested Decision: Decision of 12 March 2021 on the substance evaluation of resorcinol (EC No 203-585-2; CAS No 108-46-3)

Remedy sought by the Appellant

By the Contested Decision, the Agency required the registrants of resorcinol to submit information on a larval amphibian growth and development assay (‘LAGDA’) according to OECD test guideline 241.

A first substance evaluation of resorcinol took place in 2017. At that time, the evaluating Member State competent authority considered that performing a LAGDA would not provide relevant new information on the endocrine disrupting properties of resorcinol. The Contested Decision was adopted following a second substance evaluation of resorcinol conducted by another evaluating Member State competent authority.


Related News